Evidence map›Paper›PMID 33539363›Full record

ArticlePloS one2021

Low use of condom and high STI incidence among men who have sex with men in PrEP programs.

Oskar Ayerdi Aguirrebengoa, Mar Vera García, Daniel Arias Ramírez, Natalia Gil García, Teresa Puerta López, Petunia Clavo Escribano, Juan Ballesteros Martín, Clara Lejarraga Cañas, Nuria Fernandez Piñeiro, Manuel Enrique Fuentes Ferrer and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05492565 (A Study to Evaluate Clinical Benefits and Drawbacks of Antiretroviral Drugs as Pre-exposure Prophylaxis to Prevent HIV Infection Under Real-life Conditions Among Persons Who Pursue High-risk Sexual Practices), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05492565 enrolling by invitationnot on this map

A Study to Evaluate Clinical Benefits and Drawbacks of Antiretroviral Drugs as Pre-exposure Prophylaxis to Prevent HIV Infection Under Real-life Conditions Among Persons Who Pursue High-risk Sexual Practices: The Seville HIV PrEP Cohort

Typeobservational_patient_registrySponsorHospitales Universitarios Virgen del RocíoRan2020 to 2030Enrolled500ConditionsHIV Infection Primary, Hepatitis, Viral, Human, Sexually Transmitted Infections, Excluding HIV and HepatitisArmsTenofovir Disoproxil Fumarate 300 MG Oral Tablet
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  16. Article
  17. Article
  18. Sexually transmitted infections in Spain: Current status.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Oskar Ayerdi AguirrebengoaCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.ORCID 0000-0002-9441-8031
Mar Vera GarcíaCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Daniel Arias RamírezMedicina Interna, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Natalia Gil GarcíaMedicina Interna, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Teresa Puerta LópezCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Petunia Clavo EscribanoCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Juan Ballesteros MartínCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Clara Lejarraga CañasCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Nuria Fernandez PiñeiroCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Manuel Enrique Fuentes FerrerServicio de Medicina Preventiva, IdISSC, Universidad Alfonso X el Sabio, Madrid, Spain.
Mónica García LoteroCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Estefanía Hurtado GallegosCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Montserrat Raposo UtrillaCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Vicente Estrada PérezUniversidad Complutense de Madrid, Madrid, Spain.
Jorge Del Romero GuerreroCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Carmen Rodríguez MartínCentro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Hospital Clínico San Carlos · ESUniversidad Complutense de Madrid · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSince the recent introduction of preexposure prophylaxis (PrEP), several studies have reported a decrease in the use of condoms and a rise in STIs among users. This rise in risk behavior associated with the advent of PrEP is known as "risk compensation." The aim of this study is to measure clinical and behavioral changes associated with the introduction of PrEP by analyzing condom use for anal intercourse, number of sexual partners, sexualized drug use and STI incidence.

methodsWe performed a retrospective descriptive study of PrEP users followed every 3months over a 2-year period spanning 2017-2019 in a referral clinic specializing in STI/HIV in Madrid, Spain. One hundred ten men who have sex with men and transgender women underwent regular screening for STIs and hepatitis C virus (HCV) infection. Sociodemographic, clinical, and behavioral data were gathered for all subjects studied.

resultsThe risk compensation observed in this study consisted primarily of a lower rate of condom use, while the number of sexual partners and recreational drug consumption remained stable. We observed a very high incidence of STIs in this sample, particularly rectal gonorrhea and chlamydia. The factors shown to be independently associated with the presence of an STI on multivariate analysis were age below 30 years and over 10 sexual partners/month.

conclusionThe incidence of STI acquisition was higher than expected, indicating a need for strategies to minimize this impact, particularly among younger individuals with a higher number of sexual partners.

Indexed as

AdultCondomsHomosexuality, MaleHumansIncidenceMalePre-Exposure ProphylaxisRisk-TakingSexually Transmitted DiseasesYoung Adult

Identifiers

PMID33539363
PMCPMC7861516
OpenAlexW3126449112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.